Profound Medical Return on Equity (ROE) Growth & History (PROF)

Profound Medical's return on equity was −67.12% for fiscal 2025.

View full Profound Medical company overview

Profound Medical annual return on equity history

Profound Medical annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−67.12%−6.41 pp
20242024-12-31−60.70%+6.88 pp
20232023-12-31−67.58%−24.54 pp
20222022-12-31−43.04%−8.54 pp
20212021-12-31−34.50%+4.21 pp
20202020-12-31−38.71%+50.81 pp
20192019-12-31−89.51%

Profound Medical return on equity trends

Over the last five fiscal years, Profound Medical's return on equity decreased from −38.71% to −67.12%, a change of −28.41 percentage points. The latest reported quarter, Q2 2026, shows −17.47%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Profound Medical source filings ↗

Community posts

It’s quiet here.

No posts about PROF yet. Start the conversation.

Write the first post